Quick Answer
Vitamin C Immune Support Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Results We found no significant difference in GVHD occurrence and levels of retinoids between the intervention and control groups at either of the two time points.
Key Takeaways
- 01Results We found no significant difference in GVHD occurrence and levels of retinoids between the intervention and control groups at either of the two time points. [Iversen PO (2026)]
- 02Conclusion Whether routine vitamin A supplementation is warranted for GVHD prevention, needs further study. [Iversen PO (2026)]
- 03Introduction Whether retinoids and carotenoids impact on graft-versus-host disease (GVHD) following allogeneic stem cell transplantation (ASCT) is unknown. [Iversen PO (2026)]
- 04Methods We conducted a 1:1 randomized controlled trial with extracorporeal photopheresis for GVHD-prophylaxis as the intervention. [Iversen PO (2026)]
The current Migaku evidence database contains 2 reusable source documents for Vitamin C Immune Support Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- Results We found no significant difference in GVHD occurrence and levels of retinoids between the intervention and control groups at either of the two time points. [Iversen PO (2026); evidence level 2]
- Conclusion Whether routine vitamin A supplementation is warranted for GVHD prevention, needs further study. [Iversen PO (2026); evidence level 2]
- Introduction Whether retinoids and carotenoids impact on graft-versus-host disease (GVHD) following allogeneic stem cell transplantation (ASCT) is unknown. [Iversen PO (2026); evidence level 2]
- Methods We conducted a 1:1 randomized controlled trial with extracorporeal photopheresis for GVHD-prophylaxis as the intervention. [Iversen PO (2026); evidence level 2]
- Resistance often develops through genetic changes in fungi, such as mutations in drug targets or increased drug efflux. [Akimbekov Nuraly S. (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources